Abstract:Variations in physiological parameters (i.e., pH, redox potential, and ions) for distinct types of diseases make them attractive targets. Ionizable groups capable of pH-dependent charge conversion impart pH-switchable materials under acid condition through the protonation effect, which stimulates the emergence of various pH-inspired materials. However, it is confusing to distinguish preferable groups for high-efficiency drug-delivery vehicles attributing to the lack of perceiving the relationship between protonation and activity. Herein, we developed a series of bioinspired ionizable glycomimetics responses to the ambient variation from physiological environment (pH 7.4) to bacterial infectious acidic microenvironment (pH 6.0) to explore the protonation-activity relationship of various ionizable groups. The nanoparticles are coated with bacterial adhesion molecules galactose and fucose to target Pseudomonas aeruginosa. Moreover, the particle cores were composed of ionizable polymers responding to acidic microenvironment changes and entrapped antibiotic payload. Ionizable glyconanoparticles targeted bacteria and local cues as triggers to transfer payloads in on-demand patterns for the inhibition of bacteria-related infection. Significantly, we find that the nanoparticles with the pH-sensitive block of ionizable poly(2-(diisopropylamino)ethyl methacrylate) (pDPA) exhibit predominant bacterial adhesion and killing and growth inhibition of biofilm in acid environment (pH 6.0) due to the ionizable polymer protonation effect with more positive charge cooperated with the lectin-targeted effect of polysaccharide causing a huge bacterial aggregation and a highly favorable germicidal effect. The nanoparticles with poly(2-(hexamethyleneimino)ethyl methacrylate) (pHMEMA) have suboptimal antibacterial activity but advanced protonation at pH 6.3 compared to pDPA at 6.1, suggesting its selection as an applicable pH-switchable group for a slightly higher acid microenvironment like tumor (pH 6.9-6.5) because of the efficient performance after protonation than at deprotonation. On the other hand, the glycomimetic containing poly(2-(dibutylamino)ethyl methacrylate) (pDBA) as a pH-sensitive moiety displayed weak antimicrobial activity and superior stability before protonation (pH 4.7), which make it possible to prevent premature drug leakage, suggesting that pDBA is a good candidate to be applied to construct pH-sensitive drug-delivery carriers for the treatment of bacteria-related infection with a low acidic microenvironment. Overall, the structure-activity relationship of ionizable glycomimetics for the inhibition of bacteria signifies not only the development of a drug-delivery system but also the mechanism-dependent treatment of nanomedicine for infectious diseases.

Enhancement of Inhibition Rate of Antibiotic against Bacteria by Molecularly Imprinted Nanoparticles Targeting Alarmone Nucleotides as Antibiotic Adjuvants

Highly Active Nanoparticles with Rapid Adsorption-Killing Mechanism for Combating Multidrug-Resistant Bacteria

Integration of Antimicrobial Peptides and Gold Nanorods for Bimodal Antibacterial Applications.

Precision Dosing of Antibiotics and Potentiators by Hypoxia-Responsive Nanoparticles for Overcoming Antibiotic Resistance in Gram-Negative Bacteria.

Mixed-charge hyperbranched polymer nanoparticles with selective antibacterial action for fighting antimicrobial resistance

An Ultrasound Activable Metal-Phenolic Network Nano-Antibiotics for in Vivo On-Site Infection Therapy

One Step Synthesis of Antimicrobial Peptide Protected Silver Nanoparticles: the Core-Shell Mutual Enhancement of Antibacterial Activity

Nanoparticles Promote Bacterial Antibiotic Tolerance Via Inducing Hyperosmotic Stress Response.

Action Programed Nanoantibiotics with pH‐Induced Collapse and Negative‐Charged‐Surface‐Induced Deformation Against Antibiotic‐Resistant Bacterial Peritonitis

Highly Efficient Disinfection Based on Multiple Enzyme-Like Activities of Cu3P Nanoparticles: A Catalytic Approach to Impede Antibiotic Resistance

Targeted polymer-based antibiotic delivery system: A promising option for treating bacterial infections via macromolecular approaches

Platensimycin-Encapsulated Poly(lactic- co-glycolic acid) and Poly(amidoamine) Dendrimers Nanoparticles with Enhanced Anti-Staphylococcal Activity in Vivo

Nanozyme-based guanidinium peptides mediate surface reactive oxygen species for multidrug resistant bacterial infection management

An Enzymatic Antibiotic Adjuvant Modulates the Infectious Microenvironment to Overcome Antimicrobial Resistance of Pathogens

Controllable Accumulation of Conjugated Polymer Nanoparticles on the Surface of Adhesive Bacteria

Improving the biocompatibility and antibacterial efficacy of silver nanoparticles functionalized with (LLRR)3 antimicrobial peptide

A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics

Inhibition of Pathogen Adhesion by Bacterial Outer Membrane‐Coated Nanoparticles

Synthesis of peptidomimetics as antibiotic adjuvants for combination with aztreonam to combat MDR Pseudomonas aeruginosa

Peptide-Based Nano-Antibiotic Transformers with Antibiotic Adjuvant Effect for Multidrug Resistant Bacterial Pneumonia Therapy

Protonation-Activity Relationship Of Bioinspired Ionizable Glycomimetics For The Growth Inhibition Of Bacteria